H Deeg, MD, Oncology, Seattle, WA, Seattle Cancer Care Alliance


Oncology Seattle, WA

Hematologic Oncology

Professor, Medicine, University of Washington School of Medicine

Dr. Deeg is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Deeg's full profile

Already have an account?

Education & Training

  • Genesee HospitalResidency, Internal Medicine, 1973 - 1976
  • University of Bonn Faculty of Medicine
    University of Bonn Faculty of MedicineClass of 1973

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1976 - 2021
  • DC State Medical License
    DC State Medical License 1975 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations


Journal Articles

  • Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?  
    Vaughn,J.E., Anwer,F., Deeg,H.J., Vox Sang., 1/1/2016
  • Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission  
    Walter,R.B., Sandmaier,B.M., Storer,B.E., Godwin,C.D., Buckley,S.A., Pagel,J.M., Sorror,M.L., Deeg,H.J., Storb,R., Appelbaum,F.R., Biol Blood Marrow Transplant, 1/1/2015
  • Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation  
    Au,B.K., Gooley,T.A., Armand,P., Fang,M., Madtes,D.K., Sorror,M.L., Boeckh,M.J., Gibson,C.J., Deeg,H.J., Storb,R., Appelbaum,F.R., Chien,J.W., Martin,P.J., Biol Blood Marrow Transplant, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • Determining eligibility for autologous hematopoietic cell transplantation
    Holmberg,L.A., Deeg,H.J., Sandmaier,B.M., 1/1/2011


  • Hematopoietic cell transplantation for myelofibrosis 
    Gerds,A.T., Scott,B.L., Deeg,H.J., Myeloproliferative Neoplasms: A Clinicians Guide App (eBook),
  • Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience 
    Yusuf, U., Frangoul, H.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Deeg, H.J., Appelbaum, F.R., Anasetti, C., Storb, R., Sanders, J.E, Bone Marrow Transplant. Advance online
  • Hematopoietic cell transplantation for myelodysplastic syndromes (MDS). 
    Scott,B., Deeg,H.J., The MDS News
  • Join now to see all

Grant Support

  • Hematopoietic Cell Transplantation And Iron OverloadNational Heart, Lung, And Blood Institute2010–2012
  • Allogeneic Hematopoietic Cell Transplantation For Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2006–2010
  • Cell Death And Clonal Survival In Myelodysplastic Syndr*National Heart, Lung, And Blood Institute2005–2008
  • WT1 Expression In Patients With MDS Treated With ATG An*National Cancer Institute2006–2007
  • Transplants For Myelodysplasia And MyelofibrosisNational Heart, Lung, And Blood Institute2001–2003
  • Novel Therapeutic Strategies In Myelodysplastic SyndromeNational Cancer Institute2000–2003
  • Cancer Following Bone Marrow TransplantationDivision Of Cancer Epidemiology And Genetics1997–2000
  • Cancer Following Bone Marrow TransplantationDivision Of Cancer Epidemiology And Genetics1992–1996
  • International Workshop On Bone Marrow FailureNational Heart, Lung, And Blood Institute1995
  • Transfusion Sensitization In Normal RecipientsNational Heart, Lung, And Blood Institute1986–1987
  • Transfusion Sensitization In Normal RecipientsNational Heart, Lung, And Blood Institute1985–1986
  • In Vitro Studies In Patients Treated With Cyclosporin ANational Cancer Institute1985–1986

Hospital Affiliations